| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 208.947 | 235.839 | 347.644 | 476.828 | 373.655 | 431.442 | 433.721 | 473.998 | 268.764 | 301.021 |
| Total Income - EUR | 203.911 | 256.628 | 348.642 | 476.448 | 379.515 | 443.772 | 464.980 | 452.141 | 289.878 | 401.146 |
| Total Expenses - EUR | 165.451 | 244.218 | 263.669 | 367.033 | 285.260 | 390.103 | 369.454 | 408.612 | 286.386 | 366.653 |
| Gross Profit/Loss - EUR | 38.461 | 12.410 | 84.973 | 109.415 | 94.255 | 53.669 | 95.525 | 43.529 | 3.492 | 34.493 |
| Net Profit/Loss - EUR | 32.305 | 10.424 | 80.679 | 104.548 | 90.509 | 49.396 | 91.172 | 39.401 | 933 | 26.621 |
| Employees | 3 | 4 | 2 | 3 | 4 | 5 | 6 | 4 | 4 | 4 |
Check the financial reports for the company - Livacip Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 49.575 | 35.680 | 55.434 | 71.343 | 76.299 | 80.877 | 68.658 | 104.762 | 112.198 | 79.434 |
| Current Assets | 136.647 | 179.546 | 201.490 | 285.668 | 333.997 | 425.464 | 554.894 | 536.913 | 529.096 | 512.536 |
| Inventories | 26.387 | 77.574 | 51.878 | 57.263 | 69.528 | 114.711 | 139.407 | 145.892 | 237.042 | 276.103 |
| Receivables | 97.921 | 87.757 | 148.891 | 231.356 | 193.459 | 216.524 | 84.942 | 210.161 | 180.354 | 153.826 |
| Cash | 12.339 | 14.214 | 720 | -2.951 | 71.010 | 94.229 | 330.545 | 180.860 | 111.700 | 82.607 |
| Shareholders Funds | 50.557 | 60.465 | 140.120 | 242.097 | 327.918 | 371.097 | 448.582 | 489.375 | 444.875 | 443.617 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 135.665 | 154.761 | 116.804 | 114.913 | 82.378 | 135.244 | 174.970 | 152.300 | 196.418 | 148.353 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4120 - 4120" | |||||||||
| CAEN Financial Year |
1610
|
|||||||||
Comments - Livacip Srl